Oscar Health (NYSE:OSCR) Trading Up 4.5%

Oscar Health, Inc. (NYSE:OSCR)’s stock price rose 4.5% during trading on Tuesday . The stock traded as high as $15.52 and last traded at $15.47. Approximately 863,308 shares were traded during trading, a decline of 73% from the average daily volume of 3,184,488 shares. The stock had previously closed at $14.80.

Analyst Ratings Changes

OSCR has been the topic of several recent analyst reports. Wells Fargo & Company boosted their target price on Oscar Health from $12.00 to $20.00 and gave the stock an “overweight” rating in a report on Thursday, February 15th. TheStreet raised Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Raymond James initiated coverage on Oscar Health in a report on Friday, March 22nd. They set an “outperform” rating and a $20.00 target price on the stock. Finally, The Goldman Sachs Group boosted their target price on Oscar Health from $8.00 to $16.00 and gave the stock a “neutral” rating in a report on Friday, February 9th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $13.50.

Oscar Health Stock Performance

The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.37. The stock has a market cap of $3.58 billion, a price-to-earnings ratio of -13.09 and a beta of 1.79. The company’s 50-day simple moving average is $15.20 and its 200-day simple moving average is $10.61.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.74) by $0.08. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The firm’s quarterly revenue was up 43.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($1.05) earnings per share. Analysts predict that Oscar Health, Inc. will post -0.23 EPS for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. Formation8 GP LLC purchased a new position in Oscar Health during the 4th quarter worth approximately $47,480,000. Southeastern Asset Management Inc. TN grew its position in Oscar Health by 30.8% during the 4th quarter. Southeastern Asset Management Inc. TN now owns 14,576,904 shares of the company’s stock worth $35,859,000 after purchasing an additional 3,430,032 shares in the last quarter. Capital World Investors purchased a new position in Oscar Health during the 1st quarter worth approximately $27,427,000. Vanguard Group Inc. grew its position in Oscar Health by 18.6% during the 3rd quarter. Vanguard Group Inc. now owns 14,127,934 shares of the company’s stock worth $78,693,000 after purchasing an additional 2,211,743 shares in the last quarter. Finally, Iron Triangle Partners LP purchased a new position in Oscar Health during the 4th quarter worth approximately $18,781,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.